Skip to main content
. 2022 Aug 24;14(9):1766. doi: 10.3390/pharmaceutics14091766

Figure 1.

Figure 1

Schematic view of nomenclature for monoclonal antibodies (MAbs) (left) and general representation of their “Y” structure (right) [6]. Note the change in color, representing the differing humanization of antibodies.